Use of Proton Pump Inhibitors and Other Acid Suppressive Medications in Newly Admitted Nursing Facility Patients

Journal of the American Medical Directors Association

Volumn 8, Issue 9, 2007, Pages 607-609

  Glew, Catherine M ^a   Rentler, Russell J ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

acid suppressive medications; geriatric patients; nursing facility; Proton pump inhibitors

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; DRUG INDICATION; DRUG USE; ELDERLY CARE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GERIATRIC PATIENT; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PEPTIC ULCER; POLYPHARMACY; PRESCRIPTION; RISK BENEFIT ANALYSIS; UNITED STATES;

EID: 35848952541     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2007.07.001     Document Type: Article

References (14)

1. Noble D.W. Proton pump inhibitors and stress ulcer prophylaxis: Pause for thought?. Crit Care Med 30 5 (2002) 1175-1176
2. American Society of Health System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 50 4 (1999) 366-372
3. Heidelbaugh J.J., and Inadomi J.M. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non ICU hospitalized patients. Am J Gastroenterol 101 (2006) 2200-2205
4. Nardino R.J., Vender R.J., and Herbert P.N. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 95 (2000) 3118-3122
5. Parente F., Cucino C., Gallus S., et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: A 1 month survey. Aliment Pharmacol Ther 17 (2003) 1503-1506
6. Martin R.M., Dunn N.R., Freemantle S., and Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: Cohort studies. Br J Clin Pharmacol 50 (2000) 366-372
7. Devlin J.W., Welage L.S., and Olsen K.M. Proton pump inhibitor formulary considerations in the acutely ill: Clinical efficacy, safety and economics. Ann Pharmacother 39 (2005) 1844-1851
8. The Medical Letter. Drugs for peptic ulcer. Treat Guidel Med Lett 2 18 (2004) 9-12
9. Thjodleifsson B. Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. Drugs Aging 19 12 (2002) 911-927
10. Yang X.Y., Lewis J.D., Epstein S., and Metz D.C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296 24 (2006) 2947-2953
11. Cunningham R., Dale B., Undy B., and Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhea. J Hosp Infect 54 (2003) 243-245
12. Dial S., Delaney J.A.C., Barkun A.N., and Suissa S. Use of gastric acid suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (2005) 2989-2995
13. Dial S., Alrasadi K., Manoukian C., Huang A., and Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: Cohort and case-control studies. CMAJ 171 1 (2004) 33-38
14. Gardner T.B., and Robertson D.J. Stress ulcer prophylaxis in non critically ill patients: Less may be more. Am J Gastroenterol 101 (2006) 2206-2208